Clinical evaluation of SKF-14336 in the treatment of psychosis associated with organic brain syndrome.
D000166:Acridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D001925:Brain Damage, Chronic / Q000150:complications*; D002986:Clinical Trials as Topic; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D011569:Psychiatric Status Rating Scales
D000166:Acridines